347 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 7 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
AAGABAlpha- and gamma-adaptin binding proteinDisease related genes
Predicted intracellular proteins
Nuclear speckles
Cytosol
Renal cancer: 1.36e-4
Thyroid cancer: 9.48e-4
Expressed in all
ACKR1Atypical chemokine receptor 1 (Duffy blood group)Blood group antigen proteins
CD markers
G-protein coupled receptors
Predicted membrane proteins
Cervical cancer: 2.52e-5
Liver cancer: 1.48e-4
Thyroid cancer: 9.76e-4
Mixed
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif 5Cancer-related genes
Predicted secreted proteins
NucleoplasmRenal cancer: 2.46e-4
Thyroid cancer: 8.54e-4
Tissue enhanced
ADM2Adrenomedullin 2Predicted secreted proteins
Thyroid cancer: 2.72e-4
Tissue enhanced
ADNP2ADNP homeobox 2Predicted intracellular proteins
Transcription factors
Mitochondria
Cytosol
Renal cancer: 6.39e-5
Thyroid cancer: 9.90e-4
Mixed
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneRenal cancer: 1.40e-6
Thyroid cancer: 3.19e-5
Endometrial cancer: 6.00e-5
Ovarian cancer: 2.67e-4
Glioma: 6.07e-4
Tissue enhanced
AFF4AF4/FMR2 family member 4Cancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Thyroid cancer: 6.44e-4
Expressed in all
ALDH1B1Aldehyde dehydrogenase 1 family member B1Enzymes
Predicted intracellular proteins
Nucleoplasm
Vesicles
Mitochondria
Thyroid cancer: 1.17e-5
Renal cancer: 2.05e-4
Expressed in all
AMMECR1Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1Disease related genes
Predicted intracellular proteins
Ovarian cancer: 6.62e-5
Thyroid cancer: 8.44e-4
Mixed
ANKEF1Ankyrin repeat and EF-hand domain containing 1Predicted intracellular proteins
Nucleoli fibrillar center
Plasma membrane
Cytosol
Thyroid cancer: 1.58e-4
Lung cancer: 1.81e-4
Renal cancer: 4.44e-4
Tissue enhanced
ANTXR1Anthrax toxin receptor 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesThyroid cancer: 1.22e-5
Cervical cancer: 5.76e-4
Mixed
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Urothelial cancer: 6.19e-6
Thyroid cancer: 4.57e-5
Endometrial cancer: 5.71e-5
Tissue enriched
APLP2Amyloid beta precursor like protein 2Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesRenal cancer: 1.33e-9
Thyroid cancer: 2.90e-4
Liver cancer: 3.37e-4
Expressed in all
APODApolipoprotein DCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Plasma membraneThyroid cancer: 4.12e-4
Breast cancer: 5.51e-4
Stomach cancer: 6.02e-4
Tissue enriched
ARAP1ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1Predicted intracellular proteins
Nucleoplasm
Vesicles
Plasma membrane
Cytosol
Pancreatic cancer: 2.04e-5
Thyroid cancer: 6.41e-4
Liver cancer: 6.45e-4
Expressed in all
ARF4ADP ribosylation factor 4Plasma proteins
Predicted intracellular proteins
Liver cancer: 7.29e-7
Thyroid cancer: 9.30e-4
Expressed in all
ARFGAP3ADP ribosylation factor GTPase activating protein 3Predicted intracellular proteins
Golgi apparatus
Cytosol
Endometrial cancer: 8.97e-6
Thyroid cancer: 2.65e-4
Expressed in all
ARRDC2Arrestin domain containing 2Predicted intracellular proteins
Nucleoplasm
Cytosol
Urothelial cancer: 2.92e-4
Ovarian cancer: 5.84e-4
Cervical cancer: 5.93e-4
Thyroid cancer: 6.91e-4
Expressed in all
ASPHAspartate beta-hydroxylaseCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Endoplasmic reticulumRenal cancer: 1.57e-5
Cervical cancer: 8.07e-5
Pancreatic cancer: 1.75e-4
Lung cancer: 3.61e-4
Thyroid cancer: 4.24e-4
Expressed in all
ATG12Autophagy related 12Predicted intracellular proteins
Renal cancer: 1.54e-7
Liver cancer: 1.36e-4
Thyroid cancer: 4.99e-4
Expressed in all
B3GNT7UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7Predicted secreted proteins
Thyroid cancer: 6.00e-4
Tissue enhanced
BAG2BCL2 associated athanogene 2Plasma proteins
Predicted intracellular proteins
NucleoplasmLiver cancer: 6.72e-6
Thyroid cancer: 1.26e-4
Tissue enhanced
BCAS2BCAS2, pre-mRNA processing factorPredicted intracellular proteins
Nuclear speckles
Centrosome
Liver cancer: 8.23e-7
Prostate cancer: 4.27e-4
Thyroid cancer: 5.24e-4
Renal cancer: 6.49e-4
Ovarian cancer: 7.96e-4
Expressed in all
BCKDHABranched chain keto acid dehydrogenase E1, alpha polypeptideDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Renal cancer: 5.33e-10
Thyroid cancer: 3.27e-5
Head and neck cancer: 9.37e-4
Expressed in all
BCL2BCL2, apoptosis regulatorCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Nuclear membrane
Renal cancer: 1.29e-8
Cervical cancer: 5.13e-5
Thyroid cancer: 2.47e-4
Tissue enhanced
BDH23-hydroxybutyrate dehydrogenase 2Enzymes
Predicted intracellular proteins
CytosolRenal cancer: 4.45e-13
Lung cancer: 1.20e-4
Endometrial cancer: 5.21e-4
Thyroid cancer: 7.75e-4
Expressed in all
BEX1Brain expressed X-linked 1Predicted intracellular proteins
Renal cancer: 8.16e-8
Breast cancer: 6.43e-4
Thyroid cancer: 6.88e-4
Tissue enhanced
BNIP3LBCL2 interacting protein 3 likeCancer-related genes
Predicted membrane proteins
Transporters
Nuclear speckles
Mitochondria
Renal cancer: 5.92e-5
Thyroid cancer: 3.95e-4
Expressed in all
BNIPLBCL2 interacting protein likePredicted intracellular proteins
Predicted membrane proteins
CytosolThyroid cancer: 4.32e-4
Endometrial cancer: 6.50e-4
Group enriched
C11orf63Chromosome 11 open reading frame 63Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Endometrial cancer: 7.94e-5
Thyroid cancer: 2.58e-4
Renal cancer: 8.77e-4
Tissue enhanced
C14orf119Chromosome 14 open reading frame 119Predicted intracellular proteins
Mitochondria
Cytosol
Thyroid cancer: 3.30e-5
Liver cancer: 5.42e-5
Expressed in all
CALM2Calmodulin 2Cancer-related genes
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Transporters
Thyroid cancer: 1.94e-5
Liver cancer: 8.35e-5
Endometrial cancer: 4.84e-4
Breast cancer: 5.05e-4
Expressed in all
CALM3Calmodulin 3Cancer-related genes
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Transporters
Lung cancer: 2.07e-4
Thyroid cancer: 9.10e-4
Expressed in all
CANXCalnexinCancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Endoplasmic reticulumColorectal cancer: 1.38e-4
Thyroid cancer: 3.17e-4
Expressed in all
CBLN1Cerebellin 1 precursorPredicted secreted proteins
Thyroid cancer: 7.10e-4
Tissue enhanced
CCDC148Coiled-coil domain containing 148Predicted intracellular proteins
Nucleus
Nucleoli
Thyroid cancer: 2.54e-4
Tissue enhanced
CCDC163Coiled-coil domain containing 163Predicted membrane proteins
Thyroid cancer: 5.05e-4
Tissue enhanced
CCDC93Coiled-coil domain containing 93Predicted intracellular proteins
Vesicles
Plasma membrane
Liver cancer: 2.97e-6
Thyroid cancer: 9.66e-4
Expressed in all
CCND2Cyclin D2Cancer-related genes
Disease related genes
Predicted intracellular proteins
NucleoplasmThyroid cancer: 9.76e-5
Pancreatic cancer: 2.52e-4
Mixed
CCND3Cyclin D3Cancer-related genes
Predicted intracellular proteins
Thyroid cancer: 8.08e-6
Expressed in all
CCNJLCyclin J likePredicted intracellular proteins
Nuclear specklesThyroid cancer: 7.10e-4
Colorectal cancer: 7.31e-4
Urothelial cancer: 8.02e-4
Tissue enhanced
CD151CD151 molecule (Raph blood group)Blood group antigen proteins
CD markers
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Liver cancer: 5.58e-4
Thyroid cancer: 6.92e-4
Lung cancer: 9.46e-4
Expressed in all
CD47CD47 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Plasma membrane
Thyroid cancer: 7.29e-5
Renal cancer: 1.69e-4
Endometrial cancer: 2.44e-4
Expressed in all
CD9CD9 moleculeCancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 6.49e-5
Thyroid cancer: 8.93e-5
Pancreatic cancer: 1.59e-4
Expressed in all
CDC14BCell division cycle 14BEnzymes
Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmRenal cancer: 2.97e-10
Thyroid cancer: 2.82e-4
Mixed
CERS5Ceramide synthase 5Enzymes
Predicted membrane proteins
Nucleus
Nucleoli
Renal cancer: 9.33e-11
Liver cancer: 4.63e-5
Thyroid cancer: 5.76e-5
Expressed in all
CHPT1Choline phosphotransferase 1Enzymes
Predicted membrane proteins
VesiclesThyroid cancer: 7.41e-4
Expressed in all
CILPCartilage intermediate layer proteinDisease related genes
Predicted secreted proteins
Thyroid cancer: 2.24e-5
Tissue enhanced
CITED1Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Thyroid cancer: 3.95e-4
Testis cancer: 6.10e-4
Tissue enriched
CKLFChemokine like factorPredicted membrane proteins
Predicted secreted proteins
VesiclesRenal cancer: 1.06e-9
Liver cancer: 5.67e-5
Thyroid cancer: 2.22e-4
Expressed in all
Page of 7 | next »